It is not for human or veterinary consumption, and not for drug, household, or other uses
Based on these studies the US FDA has recently approved high dose Semaglutide 2.4mg weekly as a weight loss drug
Health Canada Semaglutide data exclusivity and patent status Data exclusivity expired Jan 4, 2026
It has been found to exert a wide array of beneficial effects, including anti-inflammatory properties and the ability to promote angiogenesis (the formation of new blood vessels), which is crucial for tissue repair and regeneration
IGF-1 is produced throughout ones lifespan, typically peaking around puberty (6)
However, there is no research to substantiate such a dosing regime or a dosage cycle